This report describes a 4-year prospective, observational assessment of fecal microbiota transplantation (FMT) performed in 681 health care facilities across 50 U.S. states and 7
C difficile infection
C difficile infection
Real-world Efficacy of Fecal Microbiota Transplantation for All C difficile Infection Subtypes: 81% for Recurrent, 78% for Refractory, 71% for Severe
Oral Microbiome Therapy Made of Purified Firmicutes Spores Effective for Treatment of Recurrent C difficile Infection
This study was a double-blind, randomized, placebo-controlled trial. It included patients with ≥3 episodes of C difficile infection (CDI) within 12 months, including the qualifying acute episode.
